Pharmacokinetics and safety of a single dose of telavancin in pediatric subjects 2–17 years of age
- DOI
- 10.1128/aac.00987-23
- Published
- 2023-11-15
- Container
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1128/aac.00987-23,
title = {Pharmacokinetics and safety of a single dose of telavancin in pediatric subjects 2–17 years of age},
author = {John S. Bradley and Jennifer L. Goldman and Laura P. James and Byron Kaelin and Breanne H. Y. Gibson and Antonio Arrieta},
year = {2023},
journal = {Antimicrobial Agents and Chemotherapy},
doi = {10.1128/aac.00987-23},
url = {https://doi.org/10.1128/aac.00987-23}
}RIS
TY - JOUR TI - Pharmacokinetics and safety of a single dose of telavancin in pediatric subjects 2–17 years of age AU - John S. Bradley AU - Jennifer L. Goldman AU - Laura P. James AU - Byron Kaelin AU - Breanne H. Y. Gibson AU - Antonio Arrieta PY - 2023 JO - Antimicrobial Agents and Chemotherapy DO - 10.1128/aac.00987-23 UR - https://doi.org/10.1128/aac.00987-23 ER -
APA
Bradley, J. S., Goldman, J. L., James, L. P., Kaelin, B., Gibson, B. H. Y., & Arrieta, A. (2023). Pharmacokinetics and safety of a single dose of telavancin in pediatric subjects 2–17 years of age. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00987-23
Source records
- crossref · retrieved 2026-09-27T07:25:40.440Z